BioArctic Denmark ApS - CVR: 43775154

2023, DKK

28.06.2024

Bruttoresultat

3.177'

Primær drift

320'

Årets resultat

184'

Aktiver

1.279'

Kortfristede aktiver

1.274'

Egenkapital

424'

Afkastningsgrad

25 %

Soliditetsgrad

33 %

Likviditetsgrad

149 %

Resultat

28.06.2024

Årsrapport	2023 28.06.2024
Nettoomsætning
Bruttoresultat	3.177.364
Resultat af primær drift	319.565
Indtægter af kapitalandele (tilknyttede og associerede)	0
Finansielle indtægter	3.568
Finansieringsomkostninger	0
Andre finansielle omkostninger	-30.666
Resultat før skat	292.467
Resultat	183.915
Forslag til udbytte	0

Aktiver

28.06.2024

Årsrapport	2023 28.06.2024
Kortfristede varebeholdninger	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	469.231
Likvider	804.393
Kortfristede aktiver	1.273.624
Immaterielle aktiver og goodwill	0
Finansielle anlægsaktiver	5.000
Materielle aktiver	0
Langfristede aktiver	5.000
Aktiver	1.278.624

Aktiver

28.06.2024

Passiver

28.06.2024

Årsrapport	2023 28.06.2024
Forslag til udbytte	0
Egenkapital	423.647
Hensatte forpligtelser	0
Langfristet gæld til banker	0
Leverandører af varer og tjenesteydelser	249.153
Kortfristede forpligtelser	854.977
Gældsforpligtelser	854.977
Forpligtelser	854.977
Passiver	1.278.624

Passiver

28.06.2024

Nøgletal

28.06.2024

Årsrapport	2023 28.06.2024
Afkastningsgrad	25,0 %
Dækningsgrad	Na.
Resultatgrad	Na.
Varelagerets omsætningshastighed	Na.
Egenkapitals-forretning	43,4 %
Payout-ratio	Na.
Gældsdæknings-nøgletal	Na.
Soliditestgrad	33,1 %
Likviditetsgrad	149,0 %

Resultat

28.06.2024

Gæld

28.06.2024

Årsrapport

28.06.2024

Nyeste:13.01.2023- 31.12.2023(offentliggjort: 28.06.2024)

Information om virksomhedens regnskabsklasse:The annual report of BioArctic Denmark ApS for 13. 01. 2023 - 31. 12. 2023 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B with the adoption of individual rules from class C.

Oplysning om pantsætninger og sikkerhedsstillelser:3. Collaterals and securities No securities or mortgages exist at the balance sheet date.

Beretning

28.06.2024

Dato for ledelsens godkendelse af årsrapporten:2024-06-27

Ledelsespåtegning: Today, Management has considered and adopted the Annual Report of BioArctic Denmark ApS for the financial year 13 January 2023 - 31 December 2023. The Annual Report is presented in accordance with the Danish Financial Statements Act. In our opinion, the Financial Statements give a true and fair view of the assets, liabilities and financial position of the Company at 31 December 2023 and of the results of the Company's operations for the financial year 13 January 2023 - 31 December 2023. In our opinion, the Management's Review includes a true and fair account of the matters addressed in the review. The Annual General Meeting of the Company decides that the Financial Statements for next year are not to be audited. The conditions for not conducting an audit of the Financial Statements have been met. We recommend that the Annual Report be adopted at the Annual General Meeting. Herlev, 27 June 2024 Executive Board Anna-Kaija Gronblad Direktør Supervisory Board Gunilla Christina Osswald Leif Olof Francesco Gallo Anders Jussi Martin-Lof Formand Medlem Medlem

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, Management has considered and adopted the Annual Report of BioArctic Denmark ApS for the financial year 13 January 2023 - 31 December 2023.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:The Company's principal activities The company’s principal activities consist in providing sales support for power semiconductor modules, which are used in drive technology, electrical systems and regenerative power generation.